Even if emergence of NF1 mutations following targeted therapies was previously described in melanoma, and the downregulation of NF1 expression was observed in EGFR‐mutated lung adenocarcinoma,31, 32 we do not confirm this observation in our cohort. The gene discussed is NF1; the disease is melanoma.